Screener
LABU vs PILL
Direxion Daily S&P Biotech Bull 3X Shares vs Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF
Key differences
- LABU is significantly larger than PILL — larger funds tend to be more liquid and less likely to close.
- Over the last 3 years, PILL has delivered higher annualized returns.
Side-by-side comparison
| LABU | PILL | |
|---|---|---|
| Annual cost (TER) | 0.96% | 0.98% |
| Fund size (AUM) | $528M | $13M |
| Since | 2015 | 2017 |
| Dividend yield | 0.69% | 0.63% |
| Asset class | equity | equity |
| Region | north america | north america |
| Strategy | leveraged | leveraged |
| CAGR 1Y | +246.3% | +146.6% |
| CAGR 3Y | +10.2% | +15.6% |
| CAGR 5Y | -32.0% | -9.3% |
| Sharpe 3Y | 0.48 | 0.48 |
| Volatility 1Y | 75.02% | 61.07% |
| Max drawdown | -98.96% | -88.76% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to LABU and PILL
Explore further